249 related articles for article (PubMed ID: 34711640)
1. Intracellular Cholesterol Pools Regulate Oncogenic Signaling and Epigenetic Circuitries in Early T-cell Precursor Acute Lymphoblastic Leukemia.
Rashkovan M; Albero R; Gianni F; Perez-Duran P; Miller HI; Mackey AL; Paietta EM; Tallman MS; Rowe JM; Litzow MR; Wiernik PH; Luger S; Sulis ML; Soni RK; Ferrando AA
Cancer Discov; 2022 Mar; 12(3):856-871. PubMed ID: 34711640
[TBL] [Abstract][Full Text] [Related]
2. Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia.
Danis E; Yamauchi T; Echanique K; Zhang X; Haladyna JN; Riedel SS; Zhu N; Xie H; Orkin SH; Armstrong SA; Bernt KM; Neff T
Cell Rep; 2016 Mar; 14(8):1953-65. PubMed ID: 26904942
[TBL] [Abstract][Full Text] [Related]
3. Early T-Cell Precursor Leukemia: A High-Risk Subtype of Acute Lymphoblastic Leukemia, Single Center Experience in Jordan.
Halahleh K; Muradi I; Khalil MZ; Halahleh L; Sughayer M; Kamal N; Sultan I; Alrabi K
Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):e411-e419. PubMed ID: 37730482
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of adult patients with early T-cell precursor (ETP) acute lymphoblastic leukemia/lymphoma (ALL) and non-ETP T-ALL.
Onishi Y; Furukawa E; Kamata M; Fukatsu M; Kameoka Y; Hatta S; Hamada H; Oyake T; Kai T; Sukegawa M; Nakajima S; Yanagiya R; Yamaguchi K; Takahashi T; Harazaki Y; Izumi T; Murai K; Ito S; Ikezoe T; Ishizawa K; Takahashi N; Harigae H
Int J Hematol; 2023 May; 117(5):738-747. PubMed ID: 36757523
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA profiling reveals aberrant microRNA expression in adult ETP-ALL and functional studies implicate a role for miR-222 in acute leukemia.
Coskun E; Neumann M; Schlee C; Liebertz F; Heesch S; Goekbuget N; Hoelzer D; Baldus CD
Leuk Res; 2013 Jun; 37(6):647-56. PubMed ID: 23522449
[TBL] [Abstract][Full Text] [Related]
6. Emerging Necessity of Myeloid Mutational Analysis in Early T-cell Precursor Acute Lymphoblastic Leukemia/Lymphoma (ETP-ALL).
Tariq H; Shetty S
Turk J Haematol; 2023 Aug; 40(3):227-229. PubMed ID: 37431282
[No Abstract] [Full Text] [Related]
7. B-cell lymphoma/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia/lymphoma (ETP-ALL/LBL) from other subtypes of T-cell ALL/LBL.
Fang H; Wang W; El Hussein S; Morita K; Beird HC; Mitra A; Loghavi S; Lin P; Jabbour EJ; Khoury JD
Br J Haematol; 2021 Sep; 194(6):1034-1038. PubMed ID: 34402058
[TBL] [Abstract][Full Text] [Related]
8. Low LEF1 expression is a biomarker of early T-cell precursor, an aggressive subtype of T-cell lymphoblastic leukemia.
Wang M; Zhang C
PLoS One; 2020; 15(5):e0232520. PubMed ID: 32401815
[TBL] [Abstract][Full Text] [Related]
9. T-cell transcription factor GATA-3 is an immunophenotypic marker of acute leukemias with T-cell differentiation.
Dorfman DM; Morgan EA; Pelton A; Unitt C
Hum Pathol; 2017 Jul; 65():166-174. PubMed ID: 28551327
[TBL] [Abstract][Full Text] [Related]
10. Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study.
Bond J; Graux C; Lhermitte L; Lara D; Cluzeau T; Leguay T; Cieslak A; Trinquand A; Pastoret C; Belhocine M; Spicuglia S; Lheritier V; LeprĂȘtre S; Thomas X; Huguet F; Ifrah N; Dombret H; Macintyre E; Boissel N; Asnafi V
J Clin Oncol; 2017 Aug; 35(23):2683-2691. PubMed ID: 28605290
[TBL] [Abstract][Full Text] [Related]
11. Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.
Jain N; Lamb AV; O'Brien S; Ravandi F; Konopleva M; Jabbour E; Zuo Z; Jorgensen J; Lin P; Pierce S; Thomas D; Rytting M; Borthakur G; Kadia T; Cortes J; Kantarjian HM; Khoury JD
Blood; 2016 Apr; 127(15):1863-9. PubMed ID: 26747249
[TBL] [Abstract][Full Text] [Related]
12. Nras Q61R/+ and Kras-/- cooperate to downregulate Rasgrp1 and promote lympho-myeloid leukemia in early T-cell precursors.
Wen Z; Yun G; Hebert A; Kong G; Ranheim EA; Finn R; Rajagoplan A; Li S; Zhou Y; Yu M; Damnernsawad A; Roose JP; Coon JJ; Wen R; Wang D; Zhang J
Blood; 2021 Jun; 137(23):3259-3271. PubMed ID: 33512434
[TBL] [Abstract][Full Text] [Related]
13. PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis.
Lim JT; Singh N; Leuvano LA; Calvert VS; Petricoin EF; Teachey DT; Lock RB; Padi M; Kraft AS; Padi SKR
Mol Cancer Ther; 2020 Sep; 19(9):1809-1821. PubMed ID: 32753387
[TBL] [Abstract][Full Text] [Related]
14. Optimized outcome prediction of oncogenetic mutations in non-early T-cell precursor acute lymphoblastic leukemia.
Peng LJ; Wang SS; Guo SS; Zhang JJ; Liu YF; Rousseaux S; Khochbin S; Chen B; Wang J; Mi JQ
Immunobiology; 2022 May; 227(3):152205. PubMed ID: 35279479
[TBL] [Abstract][Full Text] [Related]
15. Short-course Venetoclax With Standard Chemotherapy Is Effective in Early T-cell Precursor Acute Lymphoblastic Leukemia.
Borah P; Dayal N; Pathak S; Naithani R
J Pediatr Hematol Oncol; 2023 Jul; 45(5):271-274. PubMed ID: 37027330
[TBL] [Abstract][Full Text] [Related]
16. TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia.
Tan SH; Tan TK; Yokomori R; Liao M; Huang XZ; Yeoh AEJ; Sanda T
Leukemia; 2023 Oct; 37(10):1969-1981. PubMed ID: 37591943
[TBL] [Abstract][Full Text] [Related]
17. Early T-cell precursor leukemia: a subtype of high risk childhood acute lymphoblastic leukemia.
Ma M; Wang X; Tang J; Xue H; Chen J; Pan C; Jiang H; Shen S
Front Med; 2012 Dec; 6(4):416-20. PubMed ID: 23065427
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALL.
Chopra A; Bakhshi S; Pramanik SK; Pandey RM; Singh S; Gajendra S; Gogia A; Chandramohan J; Sharma A; Kumar L; Seth R; Rai S; Kumar R
Eur J Haematol; 2014 Mar; 92(3):211-8. PubMed ID: 24329989
[TBL] [Abstract][Full Text] [Related]
19. A new hope for early T cell precursor acute lymphoblastic leukemia therapy based on STAT5+ leukemic stem cell targeting.
Pelayo R
J Leukoc Biol; 2023 Oct; 114(5):381-383. PubMed ID: 37607260
[TBL] [Abstract][Full Text] [Related]
20. Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma.
Xu X; Paxton CN; Hayashi RJ; Dunsmore KP; Winter SS; Hunger SP; Winick NJ; Carroll WL; Loh ML; Devidas M; Gross TG; Bollard CM; Perkins SL; Miles RR
Blood Adv; 2021 Jul; 5(14):2890-2900. PubMed ID: 34297047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]